V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220021753 | 220006063 | null | null | Adjuvant (A) | 2019-03-06 | 2019-04-07 | null | 02 | null | 220022911 | NOT MATCHED |
| 220021754 | 220006071 | 1.6 | null | Disease modification (D) | 2013-08-13 | 2013-11-01 | AML Downs haM | Y | N | 220022988 | NOT MATCHED |
| 220021757 | 220006090 | 1.6 | null | Disease modification (D) | null | 2014-12-16 | Hydroxycarbamide | N | N | 220023007 | HYDROXYCARBAMIDE |
| 220021758 | 220017257 | 1.75 | 26.1 | Curative (C) | 2018-07-03 | 2018-08-07 | AML MyeChild | N | N | 220023070 | NOT MATCHED |
| 220021759 | 220006147 | null | 8.4 | Palliative (P) | 2016-04-07 | 2016-04-13 | AML MyeChild 01 HD AraC | N | N | 220023293 | NOT MATCHED |
| 220021760 | 220006159 | null | 69 | Curative (C) | 2013-11-15 | 2013-11-16 | CYTARABINE | N | N | 220023340 | CYTARABINE |
| 220021761 | 220006164 | 1.44 | 13.8 | Curative (C) | 2018-07-11 | 2018-09-09 | AML Interim Guidelines FLA -Ida | 02 | N | 220023346 | NOT MATCHED |
| 220021762 | 220013316 | 1.6 | null | Disease modification (D) | 2017-12-04 | 2018-05-22 | Hydroxycarbamide | N | N | 220023471 | HYDROXYCARBAMIDE |
| 220021763 | 220017291 | null | 29 | Curative (C) | 2016-10-22 | 2016-12-03 | null | 02 | N | 220023478 | NOT MATCHED |
| 220021764 | 220006189 | null | 85 | Adjuvant (A) | 2019-03-14 | 2019-03-14 | Hydroxycarbamide | N | null | 220023489 | HYDROXYCARBAMIDE |
| 220021765 | 220006227 | 1.64 | null | null | 2016-12-29 | 2016-12-29 | CYTARABINE | N | N | 220023640 | CYTARABINE |
| 220021766 | 220006230 | 1.68 | null | Disease modification (D) | 2014-07-03 | 2014-07-03 | Hydroxycarbamide | N | N | 220023646 | HYDROXYCARBAMIDE |
| 220021767 | 220006241 | null | 79 | Curative (C) | 2017-02-15 | 2017-03-02 | null | 02 | N | 220023676 | NOT MATCHED |
| 220021768 | 220006249 | 1.66 | 0 | Curative (C) | 2018-06-28 | 2018-06-28 | CYTARABINE | N | N | 220023701 | CYTARABINE |
| 220021769 | 220006258 | 0 | 53 | Palliative (P) | 2014-04-06 | 2014-04-08 | Cytarabine Low Dose | 01 | N | 220023737 | CYTARABINE |
| 220021770 | 220006264 | null | 85 | Disease modification (D) | null | 2016-10-10 | AML Downs IT Cytarabine | null | null | 220023759 | NOT MATCHED |
| 220021771 | 220006272 | null | 12.8 | Curative (C) | 2013-09-28 | 2013-09-28 | AML Relapsed FLA - Idarubicin | null | N | 220023793 | NOT MATCHED |
| 220021772 | 220006277 | 0 | null | Disease modification (D) | 2015-04-15 | 2015-04-15 | Hydroxycarbamide | N | N | 220023811 | HYDROXYCARBAMIDE |
| 220021773 | 220013388 | 1.68 | 10.8 | Curative (C) | 2017-12-13 | 2018-03-15 | AML MyeChild 01 IT Cyt | Y | N | 220023821 | NOT MATCHED |
| 220021774 | 220006297 | null | 68 | Palliative (P) | 2019-05-20 | 2019-05-20 | Hydroxycarbamide | N | N | 220023866 | HYDROXYCARBAMIDE |
| 220021775 | 220006317 | 0 | 87.2 | Disease modification (D) | null | 2017-06-24 | Hydroxycarbamide | N | N | 220023938 | HYDROXYCARBAMIDE |
| 220021776 | 220013431 | null | 32.1 | Palliative (P) | null | 2017-04-02 | AML Downs HD Cytarabine (3+4) | N | null | 220024098 | NOT MATCHED |
| 220021778 | 220021445 | null | 68 | Disease modification (D) | 2016-01-24 | 2016-03-15 | Hydroxycarbamide | 02 | N | 220024326 | HYDROXYCARBAMIDE |
| 220021779 | 220006408 | null | 71.4 | Curative (C) | 2015-11-14 | 2015-11-17 | Rituximab | N | null | 220024353 | RITUXIMAB |
| 220021781 | 220006423 | 1.62 | null | Curative (C) | 2014-05-07 | 2014-05-07 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220024416 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021782 | 220006429 | 1.74 | 83.7 | Curative (C) | 2018-11-17 | 2018-12-16 | Rituximab | N | N | 220024432 | RITUXIMAB |
| 220021784 | 220006443 | 1.6 | 57 | Curative (C) | 2014-11-01 | 2014-11-08 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220024482 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021785 | 220006445 | 1.79 | 74 | Curative (C) | 2016-01-14 | 2016-01-14 | AML 18 TRIAL | null | N | 220024501 | AML18 TRIAL |
| 220021786 | 220020764 | 1.56 | 71.4 | Disease modification (D) | null | 2018-08-29 | Rituximab | N | N | 220024528 | RITUXIMAB |
| 220021787 | 220013541 | 1.74 | 73 | Curative (C) | 2014-10-18 | 2014-11-15 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220024689 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021788 | 220022253 | null | 106 | Disease modification (D) | 2019-04-29 | 2019-04-29 | Dasatinib | N | N | 220024708 | DASATINIB |
| 220021789 | 220021452 | 1.85 | 84.2 | Curative (C) | 2013-06-01 | 2013-06-01 | AML18 PILOT TRIAL | N | N | 220024810 | PILOT TRIAL |
| 220021790 | 220022340 | 1.68 | 53 | Curative (C) | 2015-12-22 | 2015-12-22 | Rituximab | 2 | N | 220024847 | RITUXIMAB |
| 220021792 | 220013586 | null | null | Adjuvant (A) | 2014-07-27 | 2016-08-09 | Dasatinib | N | N | 220025121 | DASATINIB |
| 220021793 | 220013613 | 1.77 | 87.5 | Curative (C) | 2016-08-24 | 2016-08-26 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220025353 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021794 | 220019557 | 1.62 | 44.4 | Curative (C) | 2015-12-25 | 2016-04-01 | AML 18 TRIAL | Y | N | 220025361 | AML18 TRIAL |
| 220021795 | 220013630 | null | 90 | null | 2016-02-12 | 2016-02-12 | Rituximab (Maintenance) | N | N | 220025425 | RITUXIMAB |
| 220021796 | 220006686 | 0 | 71.8 | Curative (C) | 2019-05-05 | 2019-07-23 | AML 18 TRIAL | N | N | 220025668 | AML18 TRIAL |
| 220021797 | 220006748 | 1.6 | 0 | null | null | 2015-11-15 | AML18 PILOT TRIAL | N | N | 220025945 | PILOT TRIAL |
| 220021798 | 220006778 | 1.72 | 85 | Curative (C) | 2014-01-30 | 2014-11-22 | Dasatinib | N | N | 220026051 | DASATINIB |
| 220021799 | 220006794 | 1.56 | 91 | Curative (C) | 2019-08-22 | 2019-11-06 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220026127 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021800 | 220006798 | 1.72 | 103.8 | Curative (C) | 2017-08-08 | 2017-08-25 | Rituximab | null | N | 220026128 | RITUXIMAB |
| 220021801 | 220006805 | 1.6 | 119 | Curative (C) | null | 2015-10-16 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220026157 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021802 | 220006820 | 1.55 | null | Palliative (P) | 2019-08-10 | 2019-08-10 | Dasatinib | 02 | N | 220026210 | DASATINIB |
| 220021803 | 220006847 | 1.52 | 74.8 | Curative (C) | 2017-08-25 | 2017-11-25 | AML 18 TRIAL | Y | N | 220026282 | AML18 TRIAL |
| 220021804 | 220006879 | 1.63 | 50 | Curative (C) | 2018-10-24 | 2018-10-24 | Rituximab | 2 | N | 220026364 | RITUXIMAB |
| 220021805 | 220006920 | 1.94 | 75 | Palliative (P) | 2017-10-28 | 2017-12-11 | Dasatinib | N | N | 220026565 | DASATINIB |
| 220021806 | 220006930 | 1.63 | 59.6 | Curative (C) | 2017-12-05 | 2018-01-04 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220026587 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021807 | 220006963 | null | 93.3 | Disease modification (D) | 2014-12-16 | 2014-12-16 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 220026693 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220021808 | 220007006 | null | 83.3 | Curative (C) | 2016-09-04 | 2016-10-17 | AML 18 Pilot Trial | N | N | 220026840 | PILOT TRIAL |